Daniel Torres Moreno

Muta Y, Linares JF, Martinez-Ordonez A, Duran A, Cid-Diaz T, Kinoshita H, Zhang X, Han Q, Nakanishi Y, Nakanishi N, Cordes T, Arora GK, Ruiz-Martinez M, Reina-Campos M, Kasashima H, Yashiro M, Maeda K, Albaladejo-Gonzalez A, Torres-Moreno D, Garcia-Solano J, Conesa-Zamora P, Inghirami G, Metallo CM, Osborne TF, Diaz-Meco MT, Moscat J. Enhanced SREBP2-driven cholesterol biosynthesis by PKClambda/iota deficiency in intestinal epithelial cells promotes aggressive serrated tumorigenesis. Nat Commun. 2023 Dec 13;14(1):8075. doi: 10.1038/s41467-023-43690-5. PubMed PMID: 38092754.

AÑO: 2023; IF: 16.6

38092754

Santaclara V, Torres-Moreno D, Bernal-Mañas CM, Isaac MA, Ortiz-Reina S, Conesa-Zamora P. Relationship between polymorphisms in the FAS/FASL death receptor system and progression of low-grade precursor lesions infected with high-risk human papilloma virus. Hum Immunol. 2021 Sep;82(9):621-624. doi: 10.1016/j.humimm.2021.06.002. Epub 2021 Jun 12. PubMed PMID: 34127318.

AÑO: 2021; IF: 2.211

34127318

García-Solano J, Turpin-Sevilla MDC, García-García F, Carbonell-Muñoz R, Torres-Moreno D, Conesa A, Conesa-Zamora P. Differences in gene expression profiling and biomarkers between histological colorectal carcinoma subsets from the serrated pathway. Histopathology. 2019 Oct;75(4):496-507. doi: 10.1111/his.13889. Epub 2019 Aug 2. PubMed PMID: 31025430.

AÑO: 2019; IF: 3.626

31025430

Romero-Cara P, Torres-Moreno D, Pedregosa J, Vílchez JA, García-Simón MS, Ruiz-Merino G, Morán-Sanchez S, Conesa-Zamora P. A FCGR3A Polymorphism Predicts Anti-drug Antibodies in Chronic Inflammatory Bowel Disease Patients Treated With Anti-TNF. Int J Med Sci. 2018 Jan 1;15(1):10-15. doi: 10.7150/ijms.22812. eCollection 2018. PubMed PMID: 29333082; PubMed Central PMCID: PMC5765734.

AÑO: 2018; IF: 2.333

29333082

García-Solano J, Turpin MC, Torres-Moreno D, Huertas-López F, Tuomisto A, Mäkinen MJ, Conesa A, Conesa-Zamora P. Two histologically colorectal carcinomas subsets from the serrated pathway show different methylome signatures and diagnostic biomarkers. Clin Epigenetics. 2018 Nov 9;10(1):141. doi: 10.1186/s13148-018-0571-3. PubMed PMID: 30413173; PubMed Central PMCID: PMC6230233.

AÑO: 2018; IF: 5.496

30413173